You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser.
Administrator
Staff member
-
cafead   Dec 10, 2024 at 11:12: AM
Administrator
Staff member
via The Phase I trial of the company’s SRSD107 siRNA therapy found the treatment to be safe and well tolerated as part of its first-in-human tests.
article source